The key risk is regime shift:
hyperscaler AI
capex pauses, programs get re-bid, and the stock mean-reverts toward lower
EMS multiples. Second-order risks: customer concentration, working-capital whiplash during ramps, and policy/tariff shocks that force costlier regionalization.